OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC

Elizabeth A. Atchison, Ahmed F. Omar, Raymond Iezzi, Andrew J. Barkmeier, Sophie J. Bakri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

PURPOSE:: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. METHODS:: This is a retrospective chart review of all patients with exudative macular degeneration treated in an intravitreal injection clinic over a 4-year period. Data on the outcome measures of interest were gathered from electronic medical records. RESULTS:: There were 556 patients who received 4,386 injections in the injection-only clinic in a total of 1,524 injection cycles. One hundred six cycles were interrupted. The most common causes for interruption were decreased vision in the injected eye (32), decreased vision in the fellow eye (23), flashing lights (6), pain (5), and irritation in the noninjected eye (2). Of patients who had interruption of the cycle, 32 had a new diagnosis (6 corneal abrasions, 6 exudative age-related macular degeneration in fellow eye). There were six instances of conversion to exudative age-related macular degeneration found in the other eye at a routine follow-up visit following the injection clinic. CONCLUSION:: An injection-only clinic may provide a reasonable approach to streamline retina practices to ensure that patients receive timely injections.

Original languageEnglish (US)
JournalRetina
DOIs
StateAccepted/In press - Oct 18 2016

Fingerprint

Intravitreal Injections
Injections
Macular Degeneration
Electronic Health Records
Ambulatory Care
Vascular Endothelial Growth Factor A
Retina
Outcome Assessment (Health Care)
Safety
Light
Pain

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Atchison, E. A., Omar, A. F., Iezzi, R., Barkmeier, A. J., & Bakri, S. J. (Accepted/In press). OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. Retina. https://doi.org/10.1097/IAE.0000000000001372

OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. / Atchison, Elizabeth A.; Omar, Ahmed F.; Iezzi, Raymond; Barkmeier, Andrew J.; Bakri, Sophie J.

In: Retina, 18.10.2016.

Research output: Contribution to journalArticle

Atchison, EA, Omar, AF, Iezzi, R, Barkmeier, AJ & Bakri, SJ 2016, 'OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC', Retina. https://doi.org/10.1097/IAE.0000000000001372
Atchison EA, Omar AF, Iezzi R, Barkmeier AJ, Bakri SJ. OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. Retina. 2016 Oct 18. https://doi.org/10.1097/IAE.0000000000001372
Atchison, Elizabeth A. ; Omar, Ahmed F. ; Iezzi, Raymond ; Barkmeier, Andrew J. ; Bakri, Sophie J. / OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. In: Retina. 2016.
@article{9a08d502837f40c480b93e1bdaca7a0e,
title = "OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC",
abstract = "PURPOSE:: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. METHODS:: This is a retrospective chart review of all patients with exudative macular degeneration treated in an intravitreal injection clinic over a 4-year period. Data on the outcome measures of interest were gathered from electronic medical records. RESULTS:: There were 556 patients who received 4,386 injections in the injection-only clinic in a total of 1,524 injection cycles. One hundred six cycles were interrupted. The most common causes for interruption were decreased vision in the injected eye (32), decreased vision in the fellow eye (23), flashing lights (6), pain (5), and irritation in the noninjected eye (2). Of patients who had interruption of the cycle, 32 had a new diagnosis (6 corneal abrasions, 6 exudative age-related macular degeneration in fellow eye). There were six instances of conversion to exudative age-related macular degeneration found in the other eye at a routine follow-up visit following the injection clinic. CONCLUSION:: An injection-only clinic may provide a reasonable approach to streamline retina practices to ensure that patients receive timely injections.",
author = "Atchison, {Elizabeth A.} and Omar, {Ahmed F.} and Raymond Iezzi and Barkmeier, {Andrew J.} and Bakri, {Sophie J.}",
year = "2016",
month = "10",
day = "18",
doi = "10.1097/IAE.0000000000001372",
language = "English (US)",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC

AU - Atchison, Elizabeth A.

AU - Omar, Ahmed F.

AU - Iezzi, Raymond

AU - Barkmeier, Andrew J.

AU - Bakri, Sophie J.

PY - 2016/10/18

Y1 - 2016/10/18

N2 - PURPOSE:: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. METHODS:: This is a retrospective chart review of all patients with exudative macular degeneration treated in an intravitreal injection clinic over a 4-year period. Data on the outcome measures of interest were gathered from electronic medical records. RESULTS:: There were 556 patients who received 4,386 injections in the injection-only clinic in a total of 1,524 injection cycles. One hundred six cycles were interrupted. The most common causes for interruption were decreased vision in the injected eye (32), decreased vision in the fellow eye (23), flashing lights (6), pain (5), and irritation in the noninjected eye (2). Of patients who had interruption of the cycle, 32 had a new diagnosis (6 corneal abrasions, 6 exudative age-related macular degeneration in fellow eye). There were six instances of conversion to exudative age-related macular degeneration found in the other eye at a routine follow-up visit following the injection clinic. CONCLUSION:: An injection-only clinic may provide a reasonable approach to streamline retina practices to ensure that patients receive timely injections.

AB - PURPOSE:: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. METHODS:: This is a retrospective chart review of all patients with exudative macular degeneration treated in an intravitreal injection clinic over a 4-year period. Data on the outcome measures of interest were gathered from electronic medical records. RESULTS:: There were 556 patients who received 4,386 injections in the injection-only clinic in a total of 1,524 injection cycles. One hundred six cycles were interrupted. The most common causes for interruption were decreased vision in the injected eye (32), decreased vision in the fellow eye (23), flashing lights (6), pain (5), and irritation in the noninjected eye (2). Of patients who had interruption of the cycle, 32 had a new diagnosis (6 corneal abrasions, 6 exudative age-related macular degeneration in fellow eye). There were six instances of conversion to exudative age-related macular degeneration found in the other eye at a routine follow-up visit following the injection clinic. CONCLUSION:: An injection-only clinic may provide a reasonable approach to streamline retina practices to ensure that patients receive timely injections.

UR - http://www.scopus.com/inward/record.url?scp=84992093328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992093328&partnerID=8YFLogxK

U2 - 10.1097/IAE.0000000000001372

DO - 10.1097/IAE.0000000000001372

M3 - Article

JO - Retina

JF - Retina

SN - 0275-004X

ER -